Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.52%581.8M | 37.39%538M | 8.08%420.2M | 17.56%1.72B | 16.89%392.4M | 10.08%546.2M | 9.26%391.6M | 42.99%388.8M | 15.80%1.46B | 3.13%335.7M |
| Net income from continuing operations | 25.70%238.7M | 4.65%216.2M | 9.96%184.3M | 16.75%741.5M | 25.64%177.4M | -9.18%189.9M | 20.61%206.6M | 47.67%167.6M | 6.44%635.1M | -0.91%141.2M |
| Operating gains losses | 85.71%-100K | 72.22%-2M | ---- | -387.04%-15.5M | -179.55%-7M | 94.66%-700K | -278.95%-7.2M | -184.48%-9.8M | -71.43%5.4M | -46.34%8.8M |
| Depreciation and amortization | -8.29%213.6M | -10.02%213.8M | -8.85%215.3M | 3.77%943.3M | 2.38%236.6M | -2.47%232.9M | -5.19%237.6M | 25.31%236.2M | 18.41%909M | 21.70%231.1M |
| Asset impairment expenditure | 157.14%3.6M | -88.75%900K | -75.00%600K | 177.65%23.6M | 2,260.00%11.8M | -82.50%1.4M | --8M | --2.4M | 129.73%8.5M | -44.44%500K |
| Unrealized gains and losses of investment securities | --0 | --0 | ---- | --0 | 15,600.00%15.5M | --0 | -2,000.00%-5.7M | --0 | -150.00%-400K | ---100K |
| Deferred tax | 150.49%25.8M | -221.21%-8M | 48.01%-14.4M | 16.42%7.8M | 37.78%18.6M | -28.47%10.3M | 2,100.00%6.6M | -28.84%-27.7M | 110.58%6.7M | 227.36%13.5M |
| Other non cashItems | 44.44%2.6M | 36.36%1.5M | -280.00%-5.4M | -147.14%-3.3M | -512.50%-9.8M | -60.87%1.8M | -65.63%1.1M | 275.00%3M | 438.46%7M | 52.94%-1.6M |
| Change In working capital | -11.75%97.6M | 308.66%115.6M | 132.75%39.8M | 119.80%21.6M | 12.13%-50.7M | 218.73%110.6M | 15.29%-55.4M | 182.61%17.1M | -72.90%-109.1M | -465.69%-57.7M |
| -Change in receivables | ---- | ---- | ---- | 80.52%-27.6M | ---- | ---- | ---- | ---- | -1,716.67%-141.7M | ---- |
| -Change in inventory | ---- | ---- | ---- | 114.73%3.8M | ---- | ---- | ---- | ---- | 81.39%-25.8M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -128.69%-24.9M | ---- | ---- | ---- | ---- | 7.16%86.8M | ---- |
| -Change in other working capital | ---- | ---- | ---- | 347.54%70.3M | ---- | ---- | ---- | ---- | -1,334.78%-28.4M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.52%581.8M | 37.39%538M | 8.08%420.2M | 17.56%1.72B | 16.89%392.4M | 10.08%546.2M | 9.26%391.6M | 42.99%388.8M | 15.80%1.46B | 3.13%335.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 25.34%-141.7M | 60.16%-166.4M | 19.94%-163M | 65.57%-921.9M | 26.91%-110.8M | -26.53%-189.8M | 81.19%-417.7M | -31.02%-203.6M | -324.12%-2.68B | -25.70%-151.6M |
| Capital expenditure reported | 19.69%-138.3M | 4.44%-163.7M | -9.81%-182.5M | -8.33%-599.5M | 41.00%-89.8M | -23.00%-172.2M | -25.96%-171.3M | ---166.2M | ---553.4M | ---152.2M |
| Net PPE purchase and sale | ---- | ---- | -50.54%18.3M | ---- | ---- | ---- | ---- | 133.79%37M | ---- | ---- |
| Net intangibles purchas and sale | --0 | --0 | --0 | -2,919.19%-298.9M | --0 | --0 | ---239.1M | -31.14%-59.8M | 89.17%-9.9M | --0 |
| Net business purchase and sale | --0 | --0 | ---- | 98.85%-23.9M | ---16.9M | --0 | 99.66%-7M | ---- | -9,264.71%-2.07B | --0 |
| Net investment purchase and sale | 104.55%800K | 112.50%100K | 107.53%1.1M | -394.29%-34.6M | -433.33%-1.6M | -528.57%-17.6M | 75.76%-800K | -2,333.33%-14.6M | -6.06%-7M | -250.00%-300K |
| Net other investing changes | ---4.2M | -660.00%-2.8M | --100K | 193.09%35M | -377.78%-2.5M | ---- | 103.73%500K | ---- | -637.14%-37.6M | 80.00%900K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 25.34%-141.7M | 60.16%-166.4M | 19.94%-163M | 65.57%-921.9M | 26.91%-110.8M | -26.53%-189.8M | 81.19%-417.7M | -31.02%-203.6M | -324.12%-2.68B | -25.70%-151.6M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 28.80%-220.8M | -6,945.78%-568.2M | 35.16%-86.5M | -160.33%-712.2M | -39.83%-277M | 12.23%-310.1M | -99.56%8.3M | 2.77%-133.4M | 245.27%1.18B | 22.22%-198.1M |
| Net issuance payments of debt | 50.16%-96.1M | -1,739.57%-377.1M | 79.76%-27M | -139.59%-458.6M | -21.31%-155.4M | 30.40%-192.8M | -98.85%23M | 69.98%-133.4M | 498.62%1.16B | 15.33%-128.1M |
| Net common stock issuance | -7.06%-44M | -7.94%-29.9M | ---59.5M | -1,370.51%-114.7M | -6,457.14%-45.9M | -478.87%-41.1M | ---27.7M | --0 | 96.71%-7.8M | 97.89%-700K |
| Cash dividends paid | -5.91%-80.7M | -7.47%-161.2M | ---- | -8.87%-301.9M | -9.24%-75.7M | -10.12%-76.2M | -8.23%-150M | ---- | 1.70%-277.3M | 0.14%-69.3M |
| Net other financing activities | ---- | ---- | ---- | -46.94%163M | --0 | ---- | 163,100.00%163M | ---- | 10,693.10%307.2M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 28.80%-220.8M | -6,945.78%-568.2M | 35.16%-86.5M | -160.33%-712.2M | -39.83%-277M | 12.23%-310.1M | -99.56%8.3M | 2.77%-133.4M | 245.27%1.18B | 22.22%-198.1M |
| Net cash flow | ||||||||||
| Beginning cash position | 55.43%70.1M | 324.01%266.7M | 764.86%96M | -75.82%11.1M | 264.14%91.4M | 40.06%45.1M | 149.60%62.9M | -75.82%11.1M | -79.79%45.9M | -73.77%25.1M |
| Current changes in cash | 373.65%219.3M | -1,004.49%-196.6M | 229.54%170.7M | 343.97%84.9M | 132.86%4.6M | 752.11%46.3M | -354.29%-17.8M | 350.24%51.8M | 80.79%-34.8M | 71.89%-14M |
| End cash Position | 216.63%289.4M | 55.43%70.1M | 324.01%266.7M | 764.86%96M | 764.86%96M | 264.14%91.4M | 40.06%45.1M | 149.60%62.9M | -75.82%11.1M | -75.82%11.1M |
| Free cash from | 18.58%443.5M | 2,090.96%374.3M | 46.01%237.7M | -8.71%820.6M | 64.90%302.6M | 5.00%374M | -108.45%-18.8M | 39.38%162.8M | 37.64%898.9M | -10.14%183.5M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.